Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EntreMed and the National Cancer Institute sign letters of intent

Aug. 12, 1997

Oncormed allowed U.S. patent for BRCA1 gene

Aug. 11, 1997

Bristol-Myers Squibb acquires broad-spectrum antitumor agents

Aug. 11, 1997

Protein kinase C inhibitors discovered at Cephalon

Aug. 8, 1997

Update on Proleukin regulatory status; Photofrin approved in Germany

Aug. 8, 1997

Matrix and Savage enter marketing agreement for AccuSite

Aug. 8, 1997

StressGen and Genzyme announce closing of joint venture

Aug. 8, 1997

Genzyme Transgenics' cancer vaccine elicits immune response in myeloma patients

Aug. 7, 1997

HemoCleanse submits 510(k) for ThermoChem-HT

Aug. 7, 1997

New agent for breast cancer in development at Zenyaku Kogyo

Aug. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
BIO 2026: Alternatives to funding orphan drugs
BioWorld
At the BIO International Convention, nonprofit and for-profit companies discussed ways to fund orphan drug development, especially for ultra-rare diseases where...
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...